Vol 70, No 6 (2019)
Clinical vignette
Published online: 2019-10-23

open access

Page views 1434
Article views/downloads 964
Get Citation

Connect on Social Media

Connect on Social Media

Excess weight loss in a patient with type 2 diabetes mellitus treated with an SGLT-2 inhibitor

Edyta Cichocka1, Janusz Gumprecht1
Pubmed: 31681978
Endokrynol Pol 2019;70(6):522-523.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Diabetology C. 2018 Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clin Diabet. 2018; 7(1): 1–90.
  2. Chao EC. SGLT-2 Inhibitors: A New Mechanism for Glycemic Control. Clin Diabetes. 2014; 32(1): 4–11.
  3. Cai X, Yang W, Gao X, et al. The Association Between the Dosage of SGLT2 Inhibitor and Weight Reduction in Type 2 Diabetes Patients: A Meta-Analysis. Obesity (Silver Spring). 2018; 26(1): 70–80.
  4. Thewjitcharoen Y, Yenseung N, Malidaeng A, et al. Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center. Diabetol Metab Syndr. 2017; 9: 96.
  5. Ferrannini G, Hach T, Crowe S, et al. Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition. Diabetes Care. 2015; 38(9): 1730–1735.